AIDS News and Research

RSS

SGLT2 inhibitors reduce inflammatory cells linked to heart disease

For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight loss and glucose lowering benefits, has been shown to also reduce inflammatory cells in the blood known to cause cardiovascular disease.

6 Oct 2026

Restoring cellular recycling helps the body clear harmful zombie cells

As we grow older, our bodies accumulate "zombie cells"-living cells that have stopped dividing or functioning normally-but linger in our tissues, contributing to chronic inflammation and age-related diseases.

5 Oct 2026

DiCE project outlines roadmap for more sustainable digital healthcare

Together, the studies demonstrate that improving healthcare sustainability requires changes across clinical workflows, logistics, product design and recovery systems rather than focusing only on materials inside individual devices.

23 Sep 2026

Congo faces unprecedented Ebola outbreak without approved vaccine protection

As the Ebola outbreak spreads unabated in the Democratic Republic of the Congo (DRC), vaccine developers are scrambling to develop and test a vaccine candidate that will target the species at its center.

21 Sep 2026

Clinicians' words hold power to heal or harm patients

Dr. Wendy Harpham was 36 years old and a successful physician who prided herself on her empathy. Then she was diagnosed with cancer.

21 Sep 2026

HIV awareness emphasizes prevention, treatment and healthy aging

About 1.2 million people in the United States are living with HIV, or human immunodeficiency virus. Because of major advances in medical treatment and technology, people with HIV are living long, healthy lives.

18 Sep 2026

SARS-CoV-2 protein ORF8 drives macrophage infection and lung inflammation

In the sickest COVID-19 patients, the SARS-CoV-2 virus doesn't just cause severe damage by directly infecting airway cells.

18 Sep 2026

Male contraception has barely changed in a century. What comes next?

A review traces more than 5,000 years of male contraception, from early penile sheaths and the development of modern condoms and vasectomy to today's search for reversible alternatives. Researchers are now testing hormonal gels, non-hormonal compounds and vas-occlusive technologies, although these approaches remain at different stages of preclinical and clinical development.

15 Sep 2026

Cancer drug eliminates HIV-infected cells in animal model study

Emory University researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.

3 Sep 2026

Nicotine e-cigarettes help more smokers quit than conventional methods

Nicotine e-cigarettes are more effective in helping people quit smoking than many conventional methods such as nicotine gums and patches and quitting with behavioural support or no support at all, an updated Cochrane review finds.

25 Aug 2026

A year after women lost weight, researchers saw which health gains lasted and which faded

Diet-induced weight loss significantly reduced predicted 10-year risks of major adverse cardiovascular events and type 2 diabetes in healthy premenopausal women with overweight, regardless of whether aerobic or resistance exercise was added. Some of these gains diminished as weight was partially regained over the following year, although greater exercise adherence was associated with less rebound in predicted diabetes risk.

25 Aug 2026

Harvard engineers develop smartphone app to aid navigation for people with blindness

For people with blindness or who have low vision, moving around independently is a daily challenge. Harvard researchers have developed a new tool that could help such people navigate more quickly and safely, using nothing but a device they likely already have – a smartphone.

24 Aug 2026

TB preventive treatment delivers real-world gains for people with HIV

Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.

17 Aug 2026

Study uncovers how brain cells coordinate movement planning

Which neurons in the brain control movements, and how? This question was addressed by a team of researchers from the fields of neuroscience and artificial intelligence in a study conducted on an animal model at the interdisciplinary research centre BrainLinks-BrainTools at the University of Freiburg.

6 Aug 2026

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

Newly-discovered protein acts as off switch for human immune cells

Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.

3 Aug 2026

Biotherapeutic metabolite repairs gut damage caused by HIV infection

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS.

30 Jul 2026

Once-weekly oral tablet proves highly effective for HIV care

An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as one of today's leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking.

29 Jul 2026

Study shows diverse healthcare choices in older adults

Preferences about healthcare-including risk aversion, openness to experimental treatments, and whether to leave treatment decisions to a doctor-vary substantially by age and sex in adults over 50.

29 Jul 2026

Integration is key to fighting global epidemics, WHO reports

The World Health Organization (WHO) today launched a new report assessing progress in implementing the Global Health Sector Strategies (GHSS) on HIV, viral hepatitis and sexually transmitted infections (STIs) for 2022–2030.

28 Jul 2026